Mitochondrial dysfunction in sporadic and genetic Alzheimer's disease

被引:106
|
作者
Hauptmann, Susanne [1 ]
Keil, Uta
Scherping, Isabel
Bonert, Astrid
Eckert, Anne
Mueller, Walter E.
机构
[1] Goethe Univ Frankfurt, Dept Pharmacol, Bioctr, D-60439 Frankfurt, Germany
[2] Univ Basel, Psychiat Clin, Neurobiol Res Lab, CH-4025 Basel, Switzerland
关键词
Alzheimer's disease; mitochondrial dysfunction; beta-amyloid; neurofibrillary tangles;
D O I
10.1016/j.exger.2006.03.012
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Increasing evidence suggests an important role of mitochondrial dysfunction in the pathogenesis of many common age-related neurodegenerative diseases, including Alzheimer's disease (AD). AD is the most common neurodegenerative disorder characterized by dementia, memory loss, neuronal apoptosis and eventually death of the affected individuals. AD is characterized by two pathologic hallmark lesions that consist of extracellular plaques of amyloid-beta peptides and intracellular neurofibrillary tangles composed of hyperphosphorylated microtubular protein tau. Even though the idea that amyloid beta peptide accumulation is the primary event in the pathogenesis of Alzheimer's disease has become the leading hypothesis, the causal link between aberrant amyloid precursor protein and tau alterations in this type of dementia remains controversial. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:668 / 673
页数:6
相关论文
共 50 条
  • [1] Mitochondrial dysfunction: the missing link between aging and sporadic Alzheimer’s disease
    Amandine Grimm
    Kristina Friedland
    Anne Eckert
    [J]. Biogerontology, 2016, 17 : 281 - 296
  • [2] Mitochondrial dysfunction: the missing link between aging and sporadic Alzheimer's disease
    Grimm, Amandine
    Friedland, Kristina
    Eckert, Anne
    [J]. BIOGERONTOLOGY, 2016, 17 (02) : 281 - 296
  • [3] Mitochondrial permeability transition pore contributes to mitochondrial dysfunction in fibroblasts of patients with sporadic Alzheimer's disease
    Jose Perez, Maria
    Ponce, Daniela P.
    Aranguiz, Alejandra
    Behrens, Maria I.
    Quintanilla, Rodrigo A.
    [J]. REDOX BIOLOGY, 2018, 19 : 290 - 300
  • [4] Mitochondrial dysfunction and Alzheimer's disease
    Maruszak, Aleksandra
    Zekanowski, Cezary
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2011, 35 (02): : 320 - 330
  • [5] MITOCHONDRIAL DYSFUNCTION IN ALZHEIMER'S DISEASE
    Kota, Lakshmi Narayanan
    Nayak, Rashmitha
    Paul, Pradip
    Viswanath, Biju
    Varghese, Mathew
    Jain, Sanjeev
    Purushottam, Meera
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S840 - S841
  • [6] Mitochondrial dysfunction and Alzheimer's disease
    Ghosh, SS
    Miller, S
    Herrnstadt, C
    Fahy, E
    Shinobu, LA
    Galasko, D
    Thal, LJ
    Beal, MF
    Howell, N
    Parker, WD
    Davis, RE
    [J]. PROGRESS IN ALZHEIMER'S AND PARKINSON'S DISEASES, 1998, 49 : 59 - 66
  • [7] Parkinsonism in genetic and sporadic Alzheimer's disease
    Levin, Johannes
    [J]. PARKINSONISM BEYOND PARKINSON'S DISEASE, 2019, 149 : 237 - 247
  • [8] A "mitochondrial cascade hypthesis" for sporadic Alzheimer's disease
    Swerdlow, RH
    Khan, SM
    [J]. MEDICAL HYPOTHESES, 2004, 63 (01) : 8 - 20
  • [9] Metabolomics and mitochondrial dysfunction in Alzheimer's disease
    Kim, Dong Hee
    Gim, Jeong-An
    Yoon, Dahye
    Kim, Suhkmann
    Kim, Heui-Soo
    [J]. GENES & GENOMICS, 2017, 39 (03) : 295 - 300
  • [10] Mechanisms of Mitochondrial Dysfunction in Alzheimer's Disease
    Cadonic, Chris
    Sabbir, Mohammad Golam
    Albensi, Benedict C.
    [J]. MOLECULAR NEUROBIOLOGY, 2016, 53 (09) : 6078 - 6090